The picky mTORC1 in metabolic enzyme degradation

Area of Science:

• Cellular Biology
• Biochemistry
• Metabolism

Background:

• Mammalian target of rapamycin complex 1 (mTORC1) is a central regulator of cell growth and metabolism.
• The mevalonate pathway is crucial for cholesterol biosynthesis and cell proliferation.
• The ubiquitin-proteasome system mediates the degradation of numerous cellular proteins.

Purpose of the Study:

• To investigate the impact of reduced mTORC1 activity on metabolic enzyme regulation.
• To identify the specific mechanisms linking mTORC1 signaling to metabolic pathways.
• To explore the role of protein degradation in mediating mTORC1-dependent metabolic control.

Main Methods:

• Cellular assays to monitor protein levels and activity.
• Biochemical analyses of enzyme function and protein interactions.
• Genetic manipulation to modulate mTORC1 signaling and E3 ligase activity.

Main Results:

• Reduced mTORC1 activity leads to the degradation of HMGCS1, a rate-limiting enzyme in the mevalonate pathway.
• This degradation is dependent on the CTLH E3 ligase complex.
• The ubiquitin-proteasome system is responsible for HMGCS1 turnover.

Conclusions:

• mTORC1 signaling directly influences the stability of metabolic enzymes.
• A novel regulatory axis exists between mTORC1, the CTLH E3 ligase, and HMGCS1 degradation.
• This finding reveals a new mechanism connecting cell growth control with metabolic homeostasis via targeted protein degradation.